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In Brief
Dahimene et al. examine the role of Cachd1, a protein with similarity to the auxiliary a 2 d subunits of voltage-gated calcium channels. They find that Cachd1 increases N-type calcium currents substantially despite having a disrupted VWA interaction domain. Cachd1 also enhances channel trafficking and inhibits responses to a 2 d-1.
INTRODUCTION
Voltage-gated calcium (Ca V ) channels are key constituents of excitable cells, including muscles, neurons, and secretory cells, and are essential for their function (for a review, see Zamponi et al., 2015) . The neuronal N-type (Ca V 2.2) and P/Q-type (Ca V 2.1) channels are critical for presynaptic release of neurotransmitters (for a review, see Nanou and Catterall, 2018) , with N-type calcium channels playing a particularly important role in primary afferent neurotransmission involving pain pathways (for a review, see McGivern and McDonough, 2004) . Ca V a1 subunits form the pore of the channels, determining their main biophysical and pharmacological properties (Zamponi et al., 2015) , but the associated b and a 2 d proteins represent auxiliary subunits that are important contributors to the trafficking and biophysical properties of the channel complexes (Gurnett et al., 1996; Leung et al., 1987; Pragnell et al., 1994; Takahashi et al., 1987) . The b subunits increase Ca V currents by binding to the intracellular I-II linker (Pragnell et al., 1994) , promoting folding (Van Petegem et al., 2004) , hyperpolarizing current activation (Stea et al., 1993) , preventing polyubiquitination (Page et al., 2016) , and inhibiting proteasomal degradation (Altier et al., 2011; Waithe et al., 2011) .
By contrast, the mechanism by which the a 2 d subunits increase trafficking and function of channel complexes is less well understood (Cantí et al., 2005; Ferron et al., 2018; Kadurin et al., 2016; Savalli et al., 2016) . The a 2 d-1 subunit, in combination with neuronal calcium channels, is the therapeutic target for gabapentinoid drugs, used for the alleviation of neuropathic pain conditions and as an add-on therapy in certain epilepsies (Field et al., 2006) , and it is therefore important to understand its mechanism of action. The a 2 d proteins undergo several post-translational processing steps, including N-glycosylation, proteolytic cleavage into a 2 and d (De Jongh et al., 1990; Ellis et al., 1988; Jay et al., 1991) , and glycosyl-phosphatidylinositol (GPI) anchoring (Davies et al., 2010) .
The recent structure of the skeletal muscle Ca V 1.1 complex (Wu et al., 2016) has revealed a complex interaction of a 2 d-1 with several extracellular loops in domains I-III of Ca V 1.1. In the present study, we have taken advantage of the insights provided by this structure to probe the role of the von Willebrand factor A (VWA) domain and investigate whether there is a role for other a 2 d domains in Ca V channel function. In previous studies, by mutating the metal ion-dependent adhesion site (MIDAS) motif in the VWA domain of a 2 d subunits, we have shown that the VWA domains of both a 2 d-1 and a 2 d-2 are key to promoting calcium channel trafficking and function (Cantí et al., 2005; Hoppa et al., 2012) . The structure confirms the interaction of the MIDAS motif with the Ca V 1.1 a1 subunit (Wu et al., 2016) . However, we also found that mutating the MIDAS motif reduced the trafficking of a 2 d-1 itself when it was expressed alone . In the present study, we have therefore taken the reciprocal step of mutating the residue in Ca V 2.2 with which a 2 d-1 is predicted to bind to examine whether other regions, such as their Cache domains, play a role in promoting Ca V 2.2 trafficking and function. The Cache domains in a 2 d-1, which have homology to domains in bacterial chemotaxis receptors (Anantharaman and Aravind, 2000) , have also been shown to interact with the Ca V 1.1 a1 subunit (Wu et al., 2016) . We have compared the effect of a 2 d-1 with that of Cachd1, identified bioinformatically to be related to a 2 d proteins (Whittaker and Hynes, 2002) . Cachd1 has a VWA domain with a disrupted MIDAS motif but retains multiple predicted Cache domains. Surprisingly, we found that expression of Cachd1 increased both Ca V 2.2 currents and cell surface trafficking in both cell lines and neurons. By contrast, expression of Cachd1 did not increase the closely related Ca V 2.1 currents, indicating that this effect shows specificity for certain calcium channels. Furthermore, Cachd1 competed with a 2 d-1 for binding to Ca V 2.2 and for its functional effects and can therefore inhibit responses to a 2 d-1.
RESULTS
Disruption of the Interaction Site between Ca V 2.2 and the a 2 d-1 VWA Domain Prevents the Interaction between a 2 d-1 and Ca V 2.2 In previous studies, we found that mutation of the MIDAS motif in a 2 d-1 and a 2 d-2 prevented the ability of these proteins to traffic Ca V 2 channels and abolished the increase in Ca V 1 and Ca V 2 currents, normally seen with wild-type (WT) a 2 d-1 and a 2 d-2 (Cantí et al., 2005; Hoppa et al., 2012) . However, trafficking of the a 2 d-1 MIDAS mutant alone to the cell surface was also impaired , and our data indicate that a 2 d-1 also interacts with the trafficking protein LRP1 via its VWA domain (Kadurin et al., 2017) . Therefore, in the present study, we took advantage of the recently described structure of the skeletal muscle calcium channel complex (Wu et al., 2016) and mutated the residue in Ca V 2.2 likely to coordinate the divalent cation together with the MIDAS interaction site of a 2 d-1. The structure of Ca V 1.1 shows this to be residue D78, which is in the first extracellular loop of domain I; it corresponds by alignment to D122 in Ca V 2.2 ( Figures 1A and 1B) . This residue was mutated to uncharged alanine to disrupt the interaction with a 2 d-1. D122A Ca V 2.2 was expressed at the same level as WT Ca V 2.2 in tsA-201 cells in the presence of b1b and a 2 d-1 (Figure 1C) . As we found previously (Kadurin et al., 2016) , Ca V 2.2 showed robust co-immunoprecipitation with a 2 d-1 (Figures 1C  and 1D ). In contrast, D122A Ca V 2.2 exhibited only very weak co-immunoprecipitation (coIP) with a 2 d-1 (Figures 1C and 1D) , confirming a key role for D122 in this interaction.
The a 2 d Homolog Cachd1 Is Expressed on the Cell Surface and Interacts with Ca V 2.2 The cryoelectron microscopy (cryo-EM) structure of Ca V 1.1 shows that a 2 d-1 has four Cache domains (Anantharaman and Aravind, 2000; Wu et al., 2016) , and there are interactions of the a1 subunit with these domains as well as with the VWA domain (Wu et al., 2016) . The a 2 d-like protein Cachd1 contains Cache domains, similar to the a 2 d subunits, but its VWA domain has a highly disrupted MIDAS motif (Whittaker and Hynes, 2002) . Indeed, in a preliminary report, Cachd1 was found to have no effect on Ca V 2.2 currents (Soubrane et al., 2012) . Because our experiments also suggest that the VWA domain has a dominant role in mediating the effects of a 2 d-1, we decided to investigate whether Cachd1 showed any residual functional effect on Ca V 2.2 function.
We initially used a construct encoding zebrafish Cachd1 (zCachd1) that had been generated in a study to identify genes underlying particular nervous system development phenotypes (H. Stickney, A. Faro, G.T.P., and S.W.W., unpublished data). We subsequently confirmed our results with the rat construct rCachd1. There is very high sequence conservation, the two proteins being 85.6% identical at the amino acid level. Using a polyclonal antibody (Ab) raised against the predicted extracellular domain of zCachd1, which also recognizes human CACHD1 (G.T.P., G.J. Wright, and S.W.W., unpublished data), we observed a major band of the predicted molecular weight (MW) in whole-cell lysate (WCL) of tsA-201 cells transfected to express either zCachd1 or rCachd1 ( Figure 1E ). Cachd1 is predicted to be an N-glycosylated protein ( Figure S1A ). For rCachd1, the MW was $168 kDa when glycosylated and $148 kDa following deglycosylation with N-Glycosidase F (PNGase F), indicating that it has up to 7 N-glycosylation sites ( Figure 1E ), agreeing with the predicted number ( Figure S1A ). The glycosylation pattern is also compatible with the prediction that Cachd1 is a type I membrane protein ( Figure S1A ), in contrast to the GPI-anchored a 2 d proteins (Davies et al., 2010) . In addition to the major Cachd1 protein band, two lower MW minor bands were observed. For rCachd1, these were $148 and $137 kDa, reduced to $133 and $119 kDa following deglycosylation ( Figure 1E ). Similar results were found for zCachd1 (Figure 1E) . Cell surface biotinylation indicated that the major band was the species on the plasma membrane ( Figure 1E ), suggesting that membrane-associated Cachd1 does not undergo posttranslational proteolytic processing, unlike a 2 d proteins.
To determine whether Cachd1 was co-localized on the cell surface with Ca V 2.2, we expressed the proteins in N2A or tsA-201 cells and imaged their localization. We found that both rCachd1 ( Figure 1F ) and zCachd1 ( Figure S1B ) were present on the cell surface, together with either WT Ca V 2.2 or D122A Ca V 2.2 and b1b. Partial co-localization of Cachd1 with Ca V 2.2-hemagglutinin (HA) on the cell surface was observed ( Figure 1F , yellow regions). Even in permeabilized cells, most of the Cachd1 appeared to be associated with the cell surface ( Figure S1B ).
We then co-expressed Ca V 2.2 with a C-terminally GFPtagged Cachd1 and found that immunoprecipitation (IP) of Cachd1_GFP with GFP Ab was able to coIP Ca V 2.2. As a control, there was no coIP of Ca V 2.2 using Cachd1 without a GFP tag ( Figure 1G ), expression of which was confirmed using Cachd1 Ab ( Figure S1C ). The interaction of Cachd1 with Ca V 2.2 was likely to be weaker than that observed for a 2 d-1 because no coIP of Cachd1 with GFP_Ca V 2.2 was observed in experiments performed under conditions similar to those shown for a 2 d-1 in Figure 1C ( Figure S1D ).
The D122A Mutation in Ca V 2.2 Prevents the Effect of a 2 d-1 but Not Cachd1 on Ca v 2.2 Currents In agreement with the coIP results, we found that expression of rCachd1 produced a consistent increase (4.5-fold) in WT Ca V 2.2 currents (in the additional presence of b1b) despite its disrupted MIDAS motif (Figures 2A-2C ).
We then examined the effect of the D122A mutation on the ability of a 2 d-1 and Cachd1 to increase Ca V 2.2 currents. We found that, although a 2 d-1 increased the maximum conductance (G max ) of WT Ca V 2.2 by 11.5-fold, it produced no increase in the case of D122A Ca V 2.2, for which the currents were of the same amplitude as WT Ca V 2.2 without a 2 d (Figures 2A-2C ). Very similar results to those observed with a 2 d-1 were obtained for a 2 d-3 ( Figure S2 ).
By contrast, we found that Cachd1 produced a similar increase (5.2-fold) in G max for D122A Ca V 2.2 to that observed for WT Ca V 2.2 (Figures 2A-2C ). This result indicates that the effect of Cachd1 is unlikely to be dependent on co-ordination of a divalent cation between its disrupted MIDAS motif and loop I of the a1 subunit and, therefore, might involve other interactions with Cachd1. Like a 2 d-1, Cachd1 induced a shift of current activation to more hyperpolarized potentials for both WT and D122A Ca V 2.2, as shown in the current-voltage (I-V) relationships ( Figure 2B ).
It is noteworthy that, for both WT Ca V 2.2 and D122A Ca V 2.2, we observed that the barium current (I Ba ) in the presence of rCachd1 had an apparent reversal potential that was $11.6 mV more negative compared with WT Ca V 2.2 currents in the Figure S1C .
presence of a 2 d-1, suggesting a possible effect of Cachd1 on ion selectivity ( Figure 2D ). Under the same recording conditions, no effect was observed of rCachd1, expressed alone, on endogenous conductances in tsA-201 cells, which might independently account for this effect on the reversal potential. Furthermore, the u-conotoxin GVIA (GVIA) completely abolished Ca V 2.2 currents when coexpressed with b1b and rCachd1, as it did when b1b and a 2 d-1 (Figures 2E and 2F) . Note that the negative shift in reversal potential induced by Cachd1, relative to a 2 d-1, remains present in this dataset prior to u-conotoxin GVIA application ( Figure 2F) . Surprisingly, rCachd1 did not increase currents through the related Ca V 2.1 channel under the same conditions, although a 2 d-1 produced the expected effect ( Figure 2G ; Figures S3A and S3B), indicating that there is selectivity in the effect of Cachd1 for specific calcium channel isoforms. (A) Example families of Ca V 2.2 currents for WT Ca V 2.2-HA (top row) and D122A Ca V 2.2-HA (bottom row), co-expressed with b1b and either no a 2 d (left), a 2 d-1 (center), or rCachd1 (right). Holding potential À80 mV, steps between À50 and +60 mV for 50 ms (top, applies to all traces). (B) Mean (± SEM) current-voltage relationships for the conditions shown in (A). WT Ca V 2.2-HA (solid circles; n = 9, 18, and 27 for no a 2 d, a 2 d-1, and Cachd1, respectively) and D122A Ca V 2.2-HA (open circles; n = 10, 11, and 21 for no a 2 d, a 2 d-1, and Cachd1, respectively) were co-expressed with b1b and either no a 2 d (blue), a 2 d-1 (red), or Cachd1 (green). The individual and mean data were fit with a modified Boltzmann equation (STAR Methods). The potential for half-maximal activation (V 50,act ) (mV) was +4.9 ± 1.3, À2.9 ± 1.6, and À4.6 ± 0.5 for WT Ca V 2.2-HA with no a 2 d, a 2 d-1 and Cachd1, respectively, and +4.5 ± 0.7, +3.7 ± 0.9, and À3.6 ± 0.7 for D122A Ca V 2.2-HA with no a 2 d, a 2 d-1, and Cachd1, respectively. ns, not significant; ***p < 0.001, ****p < 0.0001 (1-way ANOVA and Sidak's post hoc test correcting for multiple comparisons). (E) Examples of current traces at +5 mV of WT Ca V 2.2 co-expressed with b1b and either a 2 d-1 (left) or Cachd1 (right) before (control) and after application of 1 mM u-conotoxin GVIA (+ u-CTX). (F) Mean (± SEM) current-voltage relationships before the application of u-conotoxin GVIA for WT Ca V 2.2-HA co-expressed with b1b and either a 2 d-1 (red circles, n = 7) or Cachd1 (green circles, n = 6). The application of u-conotoxin GVIA (1 mM) produced a complete block of WT Ca V 2.2 co-expressed with a 2 d-1 (red triangles, n = 7) or Cachd1 (green triangles, n = 6). (G) Mean (± SEM) current-voltage relationships for Ca V 2.1 co-expressed with b1b and either no a 2 d (blue solid circles, n = 12), a 2 d-1 (red solid circles, n = 14), or Cachd1 (green solid circles, n = 12). The individual and mean data were fit with a modified Boltzmann equation (STAR Methods).
Ca V 2.2-HA was N-terminally GFP-tagged to identify all transfected cells. WT Ca V 2.2-HA was well expressed at the cell surface when co-expressed with a 2 d-1, which resulted in a 7.3-fold increase compared with its cell surface expression in the absence of a 2 d ( Figures 3A and 3C ). In contrast, D122A Ca V 2.2-HA exhibited a very low expression level at the plasma membrane, which was similar in the presence and absence of a 2 d-1 (Figures 3B and 3C ). In contrast, intracellular expression of WT or D122A Ca V 2.2-HA (Figures 3A and 3B) was not significantly different with and without a 2 d-1 ( Figure 3D ).
In the same experiment, we also investigated the effect of rCachd1 on cell surface expression of Ca V 2.2-HA. We found that it produced an increase of 2.9-fold in cell surface expression of WT Ca V 2.2-HA ( Figures 3A and 3C ). Very similar results were obtained for zCachd1 in tsA-201 cells ( Figures S4A and S4B ). Of great interest, and similar to its effect on calcium currents, is that rCachd1 increased cell surface expression of D122A Ca V 2.2-HA by an extent similar to its effect on WT Ca V 2.2-HA (a 2.7-fold increase compared with D122A Ca V 2.2-HA alone; Figures 3B and 3C). Intracellular expression of WT or D122A Ca V 2.2-HA (Figures 3A and 3B) was not significantly different with or without rCachd1 ( Figure 3D ).
To understand the mechanism of action of Cachd1, we compared the endocytosis rates of Ca V 2.2 in the presence of The data were fitted with single exponentials. The time constants of the fits were 8.5 min, 9.9 min, and 15.4 min for control, + a 2 d-1, and + rCachd1, respectively. (G) Bar chart (mean ± SEM) comparing the reduction of cell surface Ca V 2.2-BBS at 10 min for the 3 conditions. BTX-488 fluorescence was normalized to t0 for each condition. BTX-488 fluorescence was reduced by 42% ± 3% for control (blue bar, n = 743 cells), 50% ± 2% for + a 2 d-1 (red bar, n = 646 cells), and 32% ± 2% for + rCachd1 (green bar, n = 784 cells). *p = 0.0109, ****p < 0.0001 (one-way ANOVA and Bonferroni's post hoc test for multiple comparisons).
b1b and either without a 2 d or plus either a 2 d-1 or Cachd1 (Figures 3E-3G ), using a method described previously . We found that Cachd1 reduced the endocytosis rate of Ca V 2.2 ( Figures 3E-3G ). The mean endocytosis time constant was increased from 8.5 min for Ca V 2.2 + b1b to 15.4 min in the additional presence of Cachd1 ( Figure 3F ). This is unlike a 2 d-1, which has no effect on Ca V 2.2 endocytosis , a result confirmed here. This effect of Cachd1 on endocytosis may therefore contribute to the increased cell surface expression of Ca V 2.2.
The D122A Mutation Abolishes the Effect of a 2 d-1 on the Trafficking of Ca V 2.2 into Cultured Hippocampal Neurites Because we have found the presence of a 2 d to be a key regulator of trafficking of Ca V 2.2 into neuronal processes (Kadurin et al., 2016) , we investigated whether the D122A mutation would influence this. Cultured hippocampal neurons were transfected after 7 days in culture, by which time there was already extensive neurite outgrowth. All conditions included b1b and mCherry as a control for successful transfection. After $7 days of expression, as expected, WT Ca V 2.2-HA was strongly trafficked into hippocampal neuronal processes when co-expressed with a 2 d-1 (Figures 4A and S4C ). In contrast, there was almost no trafficking of D122A Ca v 2.2-HA into hippocampal neurites when co-expressed with a 2 d-1 (Figures 4B and 4C ). Its level in the neurites was only 6% of that of WT Ca V 2.2-HA with a 2 d-1 ( Figure 4C ). Similarly, staining the intracellular pool of Ca V 2.2 using the II-III linker Ab showed that the level of D122A Ca V 2.2-HA was only 13% of WT Ca V 2.2-HA ( Figure 4C ), further indicating that the effect of a 2 d-1 is on trafficking Ca V 2.2 into the neurites. In the absence of a 2 d-1, there was almost no trafficking of WT Ca V 2.2-HA into hippocampal neurites ( Figures 4A and 4C) . The same was true for D122A Ca V 2.2-HA, its level being similar in the presence and absence of a 2 d-1 (Figures 4B and 4C) .
We also analyzed cell surface expression of Ca V 2.2 in the cell bodies of these hippocampal neurons and found essentially the same result; the increase in cell surface expression resulting from a 2 d-1 was abrogated by the D122A mutation ( Figures 4D  and 4E ), although an intracellular signal was present for both WT and D122A Ca V 2.2-HA ( Figure 4D ).
Cachd1 Increases the Trafficking of Ca V 2.2 into Hippocampal Neurites
We therefore also investigated the effect of Cachd1 on trafficking of Ca V 2.2-HA into hippocampal neurites ( Figure 5A ). We found that it produced a consistent increase of WT Ca V 2.2-HA by 3.3-fold ( Figures 5A and 5B ), although this was less than the 6.8-fold increase produced by a 2 d-1 in the same experiment. However, in this experimental context, Cachd1 was much less able to traffic D122A Ca V 2.2-HA into neurites than WT Ca V 2.2-HA ( Figures 5A and 5B) , unlike the result observed in the N2A cell line. This result is in agreement with our previous finding that trafficking of Ca V 2.2 is more stringently controlled in neurons than in cell lines (Kadurin et al., 2016) . The preceding experiments indicate that Cachd1 does not utilize the domain I D122 interaction site on Ca V 2.2, which is required by a 2 d-1 for interaction via its MIDAS motif. Because Cachd1 still has a VWA domain, albeit with a disrupted MIDAS motif, we wondered whether Cachd1 might potentially be an antagonist at this site, interfering with the effect of a 2 d-1. We found that Cachd1 concentration-dependently reduced the coIP of a 2 d-1 with GFP_Ca V 2.2, by 71% when both cDNAs were transfected in equal amounts ( Figures 6A and 6B ), indicating that Cachd1 can obstruct the interaction site on Ca V 2.2 utilized by a 2 d-1.
Furthermore, in experiments measuring Ca V 2.2 cell surface expression ( Figures 6C and 6E) , the additional presence of Cachd1 significantly reduced the effect of a 2 d-1 on cell surface expression of Ca V 2.2-HA by 28.4% ( Figure 6E , purple bar) but had no effect on its intracellular expression ( Figure 6F ). In this experiment, the increase in cell surface expression of Ca V 2.2-HA in the presence of Cachd1 alone was 54.4% of the Ca V 2.2-HA + a 2 d-1 level ( Figure 6E , green bar), and this increase with Cachd1 was still observed for D122A Ca V 2.2 (47.9% of the Ca V 2.2 + a 2 d-1 level; Figure 6E , open green bar). The additional presence of a 2 d-1 had no effect on the increase of D122A Ca V 2.2 cell surface expression in the presence of Cachd1 ( Figure 6E , open purple bar).
In a direct parallel with these results, we observed that Cachd1 co-expression significantly reduced Ca V 2.2 currents in the presence of a2d-1, almost to the level of Ca V 2.2 currents in the presence of Cachd1 alone ( Figures 7A and 7B ), but a 2 d-1 had no effect on the ability of Cachd1 to increase D122A Ca V 2.2 currents ( Figures 7C and 7D) . Interestingly, when a 2 d-1 and Cachd1 were co-expressed, the reversal potential for WT Ca V 2.2 currents was identical to that observed with a 2 d-1 alone ( Figure 7E ), pointing to preferential a 2 d-1 interaction on the cell surface. By contrast, for D122A Ca V 2.2 currents, the reversal potential in the presence of both a 2 d-1 and Cachd1 was similar to that for Cachd1 alone ( Figure 7F ), reinforcing the evidence for a lack of interaction of this mutant with a 2 d-1.
DISCUSSION
In this study, we uncovered a mechanism for influencing Ca V 2.2 channel trafficking and function mediated by the a 2 d-like protein Cachd1, despite its VWA domain having a disrupted MIDAS motif.
We first established the importance of interaction of Ca V 2.2 with the a 2 d-1 VWA domain for its cell surface expression and function by mutating the predicted a 2 d interaction site in Ca V 2.2 (D122), which is in the first extracellular loop of domain I. This mutation completely abolished the ability of a 2 d-1 to increase the trafficking of Ca V 2.2 and to increase Ca V 2.2 currents, indicating that it is the main interaction site between the channel and a 2 d. This was confirmed by our coIP results. Surprisingly, Cachd1 consistently produced a 4.5-fold increase in Ca V 2.2 currents and also increased the cell surface expression of Ca V 2.2 by 2.9-fold. However, in contrast to a 2 d Kadurin et al., 2016 Kadurin et al., , 2017 Macabuag and Dolphin, 2015) . In a 2 d-1 and a 2 d-2, the key MIDAS motif in the VWA domain contains three polar or negatively charged residues and has the sequence DVSGS. It is these three residues (D259, S261, and S263 in rat a 2 d-1 used here), plus two others (T331 and D363) in separate loops of the VWA domain that, together with the VWA protein ligand (Ca V 2.2 in this study), coordinate a divalent cation. In a 2 d-3 and a 2 d-4, one of these other coordinating residues is non-polar, but the MIDAS motif is intact. We confirm here that the increase in Ca V 2.2 currents caused by a 2 d-3 is also abolished by the D122A mutation in Ca V 2.2. A similar result was found for the interaction of Ca V 1.2 with a 2 d-1 in an extensive site-directed mutagenesis study (Bourdin et al., 2017) .
By contrast, Cachd1 contains a VWA domain that has a disrupted MIDAS motif (DHGAS), a sequence that is conserved in the human, rat, mouse, and zebrafish Cachd1 proteins. This conservation across species supports the possibility that it may retain some function. Indeed, the ability of Cachd1 to increase the trafficking of Ca V 2.2 into hippocampal neurites was significantly reduced for D122A Ca V 2.2, suggesting that the disrupted MIDAS motif in Cachd1 may play some role in the interaction required for Ca V 2.2 trafficking into neurites. This result also indicates that there may be more stringent trafficking requirements for this channel in neurons. We drew a similar conclusion in a previous study, in which we showed that immature pro-a 2 d-1 could traffic Ca V 2.2 to the cell surface in non-neuronal cells but not into hippocampal neurites, where mature proteolytically processed a 2 d-1 was required (Kadurin et al., 2016) .
We have shown previously that, when the three polar or charged residues of the a 2 d-1 MIDAS motif are mutated to alanine, a 2 d-1 still associates with Ca V 2.2, as judged by its ability to occlude antigenic epitopes within the Cache domains of a 2 d-1 , although it fails to promote Ca V 2.2 trafficking. This indicates that there are certainly additional interaction sites as well as the MIDAS site interaction between a 2 d-1 and Ca V 2.2. The cryo-EM structure of the skeletal muscle calcium channel complex indicates clearly that a 2 d-1 interacts with Ca V 1.1 via multiple sites in addition to the divalent cationmediated VWA domain interaction, including an interaction of a Cache domain with the turret of pore loop 5 in domain III (Wu et al., 2016) . Such an interaction with the pore domain of Ca V 2.2 could also potentially explain the effect of Cachd1 on the apparent reversal potential. Because Cachd1 was able to coIP Ca V 2.2, partially co-localized with Ca V 2.2 on the cell surface of transfected cells, and also affected the reversal potential of these channels, it is clear that Cachd1 is not solely a trafficking protein but influences functional channels in the plasma membrane. The influence of another protein on the reversal potential of a channel, interpreted as an effect on its selectivity filter, has been observed previously (Stephan et al., 2018) . The lack of effect of Cachd1 on Ca V 2.1 currents may relate to a particular splice variant or be common to all isoforms of Ca V 2.1 and should allow us to localize the site of selective interaction of Cachd1 with Ca V 2.2 in the future.
The finding that Cachd1 was able to inhibit the co-IP between Ca V 2.2 and a 2 d-1 and reduce the effect of a 2 d-1 on Ca V 2.2 cell surface expression and Ca V 2.2 currents indicates that, in vivo, it could play either a positive or an inhibitory role on Ca V 2.2 currents, depending on the degree of association of the Ca V 2.2 channels with a 2 d. From mRNA expression screens, Cachd1 is widely expressed in many tissues, including the brain, lungs, and small intestine. Of particular interest here is that Cachd1 mRNA expression was highest in dorsal root ganglia of all mouse tissues examined (see the transcriptome database described in Ray et al., 2018) , raising the intriguing possibility that Cachd1 may modulate the efficacy of a 2 d-1 following neuropathic injury, a hypothesis that we will investigate in future studies.
Within the brain, there is strong expression of a 2 d-1 mRNA in the mouse hippocampus (Schlick et al., 2010) . It is expressed strongly in CA1 and also present in dentate granule neurons. Cachd1 mRNA is also expressed in the mouse hippocampus, and, within the pyramidal cell layer, it is particularly prominent in CA3 but also in CA1 (Allen Mouse Brain Atlas; mouse.brainmap.org/api/index.html). Thus, Cachd1 and a 2 d-1 are likely to be expressed in overlapping cell types in the hippocampus. Within the rat hippocampus, there is a robust signal for a 2 d-1 protein in synaptic regions, including the dentate gyrus molecular layer, the stratum lucidum of CA3, and the CA1 stratum oriens and stratum radiatum (Nieto-Rostro et al., 2014; Taylor and Garrido, 2008) ; however, there are no equivalent data available for Cachd1 because of the paucity of antibodies and lack of knockout control tissue. Furthermore, in a large-scale proteomic study of non-neuronal cell lines, several proteins interacting with Cachd1 have been described recently (Huttlin et al., 2017); this suggests other potential roles for this protein in non-excitable cells (Rutledge et al., 2017) .
In the future, it will be of great interest to determine the effect of Cachd1 on native calcium channels and whether its expression is altered in conditions such as neuropathic injury of primary afferent neurons to further elucidate its physiological role and to understand whether it competes endogenously with a 2 d-1 or other a 2 d subunits.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS

Cell lines
Cell lines were plated onto cell culture flasks, coverslips coated with poly-L-lysine, and cultured in a 5% CO 2 incubator at 37 C. tsA-201 cells (ECACC, female sex) were cultured in Dulbecco's modified Eagle's medium in the presence of 10% fetal bovine serum, penicillin, streptomycin and 2% GlutaMAX (Invitrogen). N2A cells (ATCC, male sex) used for immunocytochemistry experiments, were cultured in DMEM and OPTI-MEM (1:1), supplemented with FBS (5%), penicillin (1 unit/ml), streptomycin (1 mg/ml), and GlutaMAX (1%).
Primary Hippocampal cultures
Hippocampal neurons were obtained from P0 rat pups (Sprague-Dawley, male), as previously described (Morales et al., 2000) . All experiments were performed in accordance with the UK Home Office Animals (Scientific procedures) Act 1986, using a Schedule 1 method, with UCL ethical approval. Briefly, hippocampi were dissected and treated for 40 min at 37 C with a papain solution containing: 70 units /ml of papain, 0.2 mg/ml L-cysteine, 0.2 mg/ml bovine serum albumin (BSA), 1 mg/ml DNase and 5mg/ml glucose (all from Sigma Aldrich) in Hank's basal salt solution (HBSS) medium (Invitrogen). Hippocampi were then washed twice with plating solution (Neurobasal medium supplemented with B27 (Thermo Fisher Scientific; 2%), HEPES (10 mM), horse serum (5%), glutamine (0.5 mM) and 1 unit/ml penicillin, 1 mg/ml streptomycin), and the neurons were mechanically dissociated using fire-polished glass Pasteur pipettes with decreasing diameter. Approximately 75 3 10 3 cells in 100 ml of plating solution were seeded onto sterile 
Neuronal transfection
The hippocampal cultures were then transfected using Lipofectamine 2000, at a ratio of 1:2 to DNA mix (1 mg/ml). After 2 h, the transfection mixes were replaced with growth medium consisting of 50% conditioned and 50% fresh medium. The DNA mix consisted of cDNAs in pCAGGS encoding WT Ca V 2.2 or D122A Ca V 2.2, a 2 d-1, b1b and mCherry, at a ratio of 3:2:2:0.5. a 2 d-1 was replaced by empty vector or rCachd1 when appropriate.
Cell surface biotinylation, cell lysis, deglycosylation and immunoblotting The procedures were modified from those described in more detail previously Kadurin et al., 2016) . Briefly, 72 h after transfection, tsA-201 cells were incubated for 30 min at room temperature with 0.5 mg/ml Premium Grade EZ-link Sulfo-NHS-LC-Biotin (Thermo Scientific) in PBS and the reaction was quenched with 200 mM glycine. The cells were resuspended in PBS, pH 7.4 at 4 C containing 1% Igepal; 0.1% SDS and protease inhibitors (PI, cOmplete, Roche), to allow cell lysis, cleared by centrifugation at 18,000 3 g and assayed for total protein (Bradford assay, Biorad). Cleared WCL corresponding to 20 -40 mg total protein was mixed with Laemmli sample buffer (Davies et al., 2010) supplemented with 100 mM dithiothreitol (DTT), resolved by SDS-polyacrylamide gel electrophoresis (PAGE) on 3%-8% Tris-Acetate (Invitrogen) and transferred to polyvinylidene fluoride (PVDF) membrane (Biorad). The proteins were revealed by immunoblotting performed with the corresponding Abs essentially as described previously . The signal was obtained by HRP reaction with fluorescent product (ECL 2; Thermo Scientific) and membranes were scanned on a Typhoon 9410 phosphorimager (GE Healthcare). Biotinylated lysates (equalized to between 0.5 and 1 mg/ml total protein concentration) were applied to 40 ml prewashed streptavidin-agarose beads (Thermo Scientific) and rotated overnight at 4 C. The beads were then washed 3 times with PBS containing 0.1% Igepal and, when required, the streptavidin beads were deglycosylated for 3 h at 37 C with 1 unit of PNGase F (Roche Applied Science). The samples containing precipitated cell surface protein fractions were then analyzed by immunoblotting with the indicated Abs as described previously .
Co-Immunoprecipitation
The protocol described below was adapted from a procedure described previously (Gurnett et al., 1997) . A tsA-201 cell pellet derived from one confluent 75 cm 2 flask was resuspended in co-IP buffer (20 mM HEPES (pH 7.4), 300 mM NaCl, 1% Digitonin and PI), sonicated for 8 s at 20 kHz and rotated for 1 h at 4 C. The samples were then diluted with an equal volume of 20 mM HEPES (pH 7.4), 300 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , with PI (to 0.5% final concentration of Digitonin), mixed by pipetting and centrifuged at 20,000 x g for 20 min. The supernatants were collected and assayed for total protein (Bradford assay; Biorad). 1 mg of total protein was adjusted to 2 mg/ml with co-IP buffer and incubated overnight at 4 C with anti-GFP polyclonal Ab (1:200; BD Biosciences). 30 ml A/G PLUS Agarose slurry (Santa Cruz) was added to each tube and further rotated for 2 h at 4 C. The beads were then washed three times with co-IP buffer containing 0.2% Digitonin. The beads were then resuspended in 2 x Laemmli buffer with 100 mM DTT and analyzed alongside equalized aliquots of the initial lysate prior to co-IP by SDS-PAGE and western blotting as described above. The reverse co-IP experiments between Cachd1_GFP and Ca V 2.2-HA were performed under identical conditions except that the NaCl concentration in the co-IP buffer was 150 mM, and the beads were washed two times in co-IP buffer containing 0.1% Digitonin.
Immunocytochemistry Cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS, pH 7.4) for 5 min, incubated with blocking buffer (20% goat serum, 4% BSA in PBS) for 1 h at room temperature before being incubated with rat anti-HA (Roche) diluted 1:200 in 0.5x blocking buffer for 1 h at room temperature. When permeabilization was included, cells were permeabilized with 0.2% Triton X-100 for 5 min before being incubated with the second primary Ab, rabbit anti-Ca V 2.2 II-II loop (1:250), for 1 h at room temperature. For hippocampal neurons, primary Ab incubation was carried out at 4 C overnight. After washing, samples were incubated with secondary Abs, anti-rat Alexa Fluor 488, anti-rat Alexa Fluor 594 and anti-rabbit Alexa Fluor 488, at a dilution of 1:500 for 1 h at room temperature. 4',6-diamidine-2 0 -phenylindole dihydrochloride (DAPI) was used to visualize the nuclei. Coverslips were washed and mounted in VectaShield (Vector Laboratories).
Endocytosis assay N2A cells were transfected with a Ca V 2.2 construct tagged with a double bungarotoxin binding site epitope (Ca V 2.2-BBS) , b1b and either empty vector, a 2 d-1 or rCachd1. After 40 h expression, cells were washed twice with Krebs-Ringer solution with HEPES (KRH) (in mM; 125 NaCl, 5 KCl, 1.1 MgCl 2 , 1.2 KH 2 PO 4 , 2 CaCl 2 , 6 Glucose, 25 HEPES, 1 NaHCO 3 ) and incubated with 10 mg/ml a-bungarotoxin Alexa Fluorâ 488 conjugate (BTX-488) (Thermo Fisher Scientific) at 17 C for 30 min. The unbound BTX-488 was removed by washing with KRH, and the labeled cells were returned to 37 C for the kinetic assay. Endocytosis was terminated by fixing the cells with cold 4% PFA-sucrose in PBS at the specified time. The cells were then permeabilized and intracellular Ca V 2.2 was labeled using the rabbit anti-Ca V 2.2 II-III loop Ab as described above.
Image Analysis N2A and tsA-201 cell samples were viewed on an LSM 780 confocal microscope (Zeiss) using either 63x/1.4 or 40x/1.3 numerical aperture oil-immersion objective in 16-bit mode. The tile function (3x3 tiles, each tile consisting of 1024x1024 pixels) was used and every transfected cell within the image was analyzed to remove collection bias. Hippocampal neurons were viewed using a 20x objective (neuronal processes) or 63x objective (soma); individual neurons were selected on the basis of mCherry expression. Acquisition settings, chosen to ensure that images were not saturated, were kept constant for each experiment. Images are individual optical sections, unless otherwise stated.
Images were analyzed using ImageJ (National Institutes of Health). For N2A cells, the freehand line tool (5 pixels) was used to manually trace the plasma membrane to measure the mean intensity of cell-surface staining. Intracellular staining was measured using the freehand selection tool, excluding the nucleus and the plasma membrane. For hippocampal neurons, two concentric circles (100 and 150 mm diameter) were centered on the soma and the freehand line tool (3 pixels) was used to trace the neuronal processes between the circles, using the mCherry image as the template. The background fluorescence was measured in an area with no transfected cells and subtracted from the mean intensity.
Electrophysiology
Calcium channel currents in transfected tsA-201 cells were investigated by whole cell patch-clamp recording. The patch pipette solution contained in mM: Cs-aspartate, 140; EGTA, 5; MgCl 2 , 2; CaCl 2 , 0.1; K 2 ATP, 2; HEPES, 10; pH 7.2, 310 mOsm with sucrose. The external solution for recording Ba 2+ currents contained in mM: tetraethylammonium (TEA) Br, 160; KCl, 3; NaHCO 3 , 1.0; MgCl 2 , 1.0; HEPES, 10; glucose, 4; BaCl 2 , 1, pH 7.4, 320 mOsm with sucrose. 1 mM extracellular Ba 2+ was the charge carrier. Pipettes of resistance 2-4 MU were used. An Axopatch 1D or Axon 200B amplifier was used, and whole cell voltage-clamp recordings were sampled at 10 kHz frequency, filtered at 2 kHz and digitized at 1 kHz. 70%-80% series resistance compensation was applied, and all recorded currents were leak subtracted using P/8 protocol. Membrane potential was held at -80 mV. Analysis was performed using pCLAMP 9 (Molecular Devices) and Origin 7 (Microcal Origin, Northampton, MA). IV relationships were fit by a modified Boltzmann equation as follows: I = G max *(V-V rev ) /(1+exp(-(V-V 50, act )/k)) where I is the current density (in pA/pF), G max is the maximum conductance (in nS/pF), V rev is the apparent reversal potential, V 50, act is the midpoint voltage for current activation, and k is the slope factor.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed with GraphPad Prism 7 (GraphPad software, San Diego, CA) or Origin-Pro 2015 (OriginLab Corporation, Northampton, MA, USA). All data are shown as mean ± SEM; ''n'' refers to number of cells or neurites, unless indicated otherwise, and is given in the figure legends, together with details of statistical tests used. Experiments where representative data are shown were repeated at least 3 times, unless otherwise stated. Graphpad Prism 7 was used for statistical analysis. Statistical significance between two groups was assessed by Student's t test, as stated. One-way ANOVA and the stated post hoc analysis was used for comparison of means between three or more groups.
